Veterinary Medicine Information website

Nurexan ad us. vet. Tablette Hunde, Katzen

Authorised
  • AVENA SATIVA D2
  • COFFEA ARABICA D12
  • PASSIFLORA INCARNATA D2
  • ZINCUM ISOVALERIANICUM D4
Download as PDF

Product identification

Medicine name:
Nurexan ad us. vet. Tablette Hunde, Katzen
Active substance:
  • AVENA SATIVA D2
  • COFFEA ARABICA D12
  • PASSIFLORA INCARNATA D2
  • ZINCUM ISOVALERIANICUM D4
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • AVENA SATIVA D2
    0.60
    milligram(s)
    /
    1.00
    Tablet
  • COFFEA ARABICA D12
    0.60
    milligram(s)
    /
    1.00
    Tablet
  • PASSIFLORA INCARNATA D2
    0.60
    milligram(s)
    /
    1.00
    Tablet
  • ZINCUM ISOVALERIANICUM D4
    0.60
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Homeopathic Registration
Marketing authorisation holder:
  • Biologische Heilmittel Heel GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Biologische Heilmittel Heel GmbH
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • 402673.00.00
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 18/02/2025
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 18/02/2025
Download